MyFinsight
Home
Compare
Blog
About
Maturities of marketable
securities
$77,900K
Net cash provided by
(used in) investing...
$29,365K
Canceled cashflow
$48,535K
Net change in cash,
cash equivalents and...
-$7,364K
Canceled cashflow
$29,365K
Accounts payable
$3,159K
Stock-based compensation
expense
$1,378K
Prepaid expenses and
other current assets
-$972K
Non-cash lease expense
$795K
Depreciation expense
$488K
Other non-current
assets
-$25K
Proceeds from issuance of
common stock upon...
$42K
Purchases of marketable
securities
$48,174K
Purchases of property and
equipment
$361K
Net cash used in
operating activities
-$34,932K
Canceled cashflow
$6,817K
Net cash (used in)
provided by financing...
-$1,797K
Canceled cashflow
$42K
Net loss
-$39,343K
Accrued and other
current liabilities
-$1,124K
Operating lease liability
-$936K
Net accretion of
discounts on marketable...
$346K
Payments of deferred
offering costs
$1,839K
Back
Back
Cash Flow
Attovia Therapeutics, Inc. (ATTO)
Attovia Therapeutics, Inc. (ATTO)
source: myfinsight.com